British American Tobacco's H1 2026 report offers a progress check on its long-running pivot from traditional cigarettes toward a "smokeless" future. The company's New Category portfolio — nicotine pouches, vapour, and heated tobacco — is now central to its growth story, even as combustibles remain the primary cash engine. Investors watch these results closely because they reveal whether the transition is generating genuine profitability rather than simply top-line growth. The first half also carried added significance following a December 2025 trading update and a string of regulatory developments in key markets such as the United States.
For the six months ended June 30, 2026, British American Tobacco delivered results in line with management's own expectations on a constant-currency basis. Group revenue rose 2.9%, while adjusted diluted EPS increased 7.9%. Adjusted operating profit grew 3.5%, and the group's operating margin expanded by 30 basis points to 43.7%, reflecting stronger New Category profitability and ongoing cost savings.
New Category revenue increased 18%, with Modern Oral (nicotine pouches) up 66%, driven by the continued success of the Velo brand, including Velo Plus. Vapour revenue rose 5.3%, supported by a recovering U.S. market, while heated products lagged as glo revenue declined roughly 12% amid inventory movements and competitive pressure. Combustibles revenue grew 2.1%, helped by strong pricing, even as volumes fell 4.7%.
Management raised its full-year EPS outlook to the middle of the 5%–8% guidance range while signaling that revenue and operating profit would land near the lower end of their ranges, partly reflecting a roughly 1% transactional foreign-exchange headwind.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs with customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener can help surface trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors following British American Tobacco, it provides a structured way to identify comparable names and emerging setups.
Sentiment around British American Tobacco heading into and following the H1 2026 release has been shaped by the company's improving U.S. performance and the accelerating adoption of modern oral products. The results confirmed a return toward management's medium-term growth algorithm, which investors generally viewed as a stabilizing signal. At the same time, lingering concerns over heated-product weakness, slower-than-expected recovery in the Asia-Pacific, Middle East, and Africa (APMEA) region, and competitive pressure in the U.S. discount segment have tempered enthusiasm. The raised EPS outlook and reaffirmed commitment to a progressive dividend and £1.3 billion buyback provided a degree of support for income-focused shareholders.
Management pointed to a second-half-weighted profit profile, driven by the phasing of New Category investments and the ramp-up of cost-saving initiatives under its Fit2Win program. The company now targets roughly £700 million in annualized savings by 2028, with about £500 million expected by 2027.
Investors should watch whether Modern Oral momentum, particularly Velo and the newly launched Velo Max, continues to accelerate. The phased U.S. rollout of new Vuse vapour flavours and the expansion of heated products such as glo Hilo and Hyper Pro+ will also be important indicators of New Category traction.
On the cost and balance-sheet side, the company expects net finance costs of about £1.65 billion for the year, an underlying tax rate of 24%–25%, and leverage moving toward its 2.0–2.5x adjusted net debt to EBITDA (earnings before interest, taxes, depreciation, and amortization) target. A continued recovery in APMEA and the sustainability of U.S. combustibles pricing remain key swing factors for the second half and into 2027.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a retailer of tobacco related products
Industry Tobacco